AVITA Medical, Inc. (RCEL) key performance indicators and operating metrics (5 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Gross Profit Margin | 81.70 percent | FY2026-Q1 |
| Gross Profit Margin for Recell Products | 85.00 percent | FY2026-Q1 |
| Lease Revenue | 187K | FY2026-Q1 |
| Sales Revenue | 19.06M | FY2026-Q1 |
| Commercial Revenue | 17.1M | FY2025-Q3 |
Back to RCEL overview · RCEL earnings · RCEL holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.